I'm on the hunt for a microbial saviour – a type of virus that can treat infections rather than cause them. We all know the ...

Vermont has the second lowest state fatality rate in the US (147.9 per 100K; Hawaii 113.5/100K). Mississippi (465.6/100K) and ...

A single dose of the antiviral baloxavir marboxil (Xofluza) led to a lower incidence of influenza virus transmission to household contacts compared with placebo, a phase IIIb randomized trial ...

Kylian Mbappe of Real Madrid has been hospitalized with acute gastroenteritis, a significant blow to both the team and the inaugural tournament. The i ...

There is good evidence from clinical trials the flu vaccine can reduce the risk of a heart attack or stroke, especially if someone already has heart problems. We aren't clear exactly how this works.

Catching the flu or COVID can trigger a heart attack or stroke in vulnerable people. Here’s what we can all do to lower our risk.

Maternal Influenza A vaccination and viral infection alter gut and nasal microbial communities. Relative abundance of the top ten genera found in A) nasal and B) gut microbial communities of ...

It’s not clear what the discussion and vote at next week’s meeting on thimerosal in flu vaccines will entail, and the presenter of the information at the meeting is listed on the agenda as ...

Norovirus GII.17 accounted for < 10% of outbreaks in the US 2022-23 season, but rose to 75% during the 2024-25 season, passing the number of GII.4 outbreaks.

Vaxart, Inc., a biotechnology company focused on oral recombinant pill vaccines, announced it will release topline data from its Phase I trial on norovirus before the market opens on June 11, 2025.

Onradivir (ZSP1273) is a potent inhibitor of the PB2 subunit of influenza A virus (IAV) polymerase. Our previous, phase 2 clinical trial showed that a 600 mg regimen of onradivir initiated within 48 h ...